| UniProt ID | GLCE_HUMAN | |
|---|---|---|
| UniProt AC | O94923 | |
| Protein Name | D-glucuronyl C5-epimerase | |
| Gene Name | GLCE | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 617 | |
| Subcellular Localization |
Golgi apparatus membrane Single-pass type II membrane protein. |
|
| Protein Description | Converts D-glucuronic acid residues adjacent to N-sulfate sugar residues to L-iduronic acid residues, both in maturing heparan sulfate (HS) and heparin chains. This is important for further modifications that determine the specificity of interactions between these glycosaminoglycans and proteins.. | |
| Protein Sequence | MRCLAARVNYKTLIIICALFTLVTVLLWNKCSSDKAIQFPRRSSSGFRVDGFEKRAAASESNNYMNHVAKQQSEEAFPQEQQKAPPVVGGFNSNVGSKVLGLKYEEIDCLINDEHTIKGRREGNEVFLPFTWVEKYFDVYGKVVQYDGYDRFEFSHSYSKVYAQRAPYHPDGVFMSFEGYNVEVRDRVKCISGVEGVPLSTQWGPQGYFYPIQIAQYGLSHYSKNLTEKPPHIEVYETAEDRDKNKPNDWTVPKGCFMANVADKSRFTNVKQFIAPETSEGVSLQLGNTKDFIISFDLKFLTNGSVSVVLETTEKNQLFTIHYVSNAQLIAFKERDIYYGIGPRTSWSTVTRDLVTDLRKGVGLSNTKAVKPTKIMPKKVVRLIAKGKGFLDNITISTTAHMAAFFAASDWLVRNQDEKGGWPIMVTRKLGEGFKSLEPGWYSAMAQGQAISTLVRAYLLTKDHIFLNSALRATAPYKFLSEQHGVKAVFMNKHDWYEEYPTTPSSFVLNGFMYSLIGLYDLKETAGEKLGKEARSLYERGMESLKAMLPLYDTGSGTIYDLRHFMLGIAPNLARWDYHTTHINQLQLLSTIDESPVFKEFVKRWKSYLKGSRAKHN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 43 | Phosphorylation | AIQFPRRSSSGFRVD CCCCCCCCCCCCCCC | 30.09 | 23882029 | |
| 44 | Phosphorylation | IQFPRRSSSGFRVDG CCCCCCCCCCCCCCC | 32.44 | 27174698 | |
| 44 | O-linked_Glycosylation | IQFPRRSSSGFRVDG CCCCCCCCCCCCCCC | 32.44 | 55827439 | |
| 45 | O-linked_Glycosylation | QFPRRSSSGFRVDGF CCCCCCCCCCCCCCH | 43.10 | OGP | |
| 45 | Phosphorylation | QFPRRSSSGFRVDGF CCCCCCCCCCCCCCH | 43.10 | 27174698 | |
| 54 | Acetylation | FRVDGFEKRAAASES CCCCCHHHHHHHHHC | 45.11 | 30588931 | |
| 59 | O-linked_Glycosylation | FEKRAAASESNNYMN HHHHHHHHHCCHHHH | 36.51 | 55825171 | |
| 61 | O-linked_Glycosylation | KRAAASESNNYMNHV HHHHHHHCCHHHHHH | 28.07 | OGP | |
| 73 | Phosphorylation | NHVAKQQSEEAFPQE HHHHHHHHHHHCCHH | 34.60 | 29255136 | |
| 98 | Ubiquitination | FNSNVGSKVLGLKYE CCCCCCHHCCCCEEE | 35.23 | 21890473 | |
| 103 | Ubiquitination | GSKVLGLKYEEIDCL CHHCCCCEEEEEEEE | 49.14 | 22817900 | |
| 104 | Ubiquitination | SKVLGLKYEEIDCLI HHCCCCEEEEEEEEE | 24.68 | 21890473 | |
| 109 | Ubiquitination | LKYEEIDCLINDEHT CEEEEEEEEECCCCC | 5.16 | 22817900 | |
| 118 | Ubiquitination | INDEHTIKGRREGNE ECCCCCCCCCCCCCE | 47.74 | 29967540 | |
| 140 | Phosphorylation | VEKYFDVYGKVVQYD HHHHHCEECEEEEEC | 17.05 | 21253578 | |
| 225 | N-linked_Glycosylation | GLSHYSKNLTEKPPH HHHHCCCCCCCCCCC | 46.37 | 19159218 | |
| 302 | Phosphorylation | SFDLKFLTNGSVSVV EEEEEECCCCCEEEE | 40.44 | 26074081 | |
| 303 | N-linked_Glycosylation | FDLKFLTNGSVSVVL EEEEECCCCCEEEEE | 42.78 | 30872481 | |
| 305 | Phosphorylation | LKFLTNGSVSVVLET EEECCCCCEEEEEEE | 17.18 | 26074081 | |
| 307 | Phosphorylation | FLTNGSVSVVLETTE ECCCCCEEEEEEECC | 14.27 | 26074081 | |
| 371 | Acetylation | LSNTKAVKPTKIMPK CCCCCCCCCCCCCCH | 52.40 | 19817253 | |
| 393 | N-linked_Glycosylation | KGKGFLDNITISTTA CCCCCHHCEEEECHH | 35.14 | 30872481 | |
| 409 | Phosphorylation | MAAFFAASDWLVRNQ HHHHHHHHHHHHHCC | 26.37 | 22210691 | |
| 436 | Phosphorylation | KLGEGFKSLEPGWYS ECCCCCCCCCCCHHH | 35.39 | 23663014 | |
| 442 | Phosphorylation | KSLEPGWYSAMAQGQ CCCCCCHHHHHHHHH | 7.77 | 23663014 | |
| 443 | Phosphorylation | SLEPGWYSAMAQGQA CCCCCHHHHHHHHHH | 12.69 | 23663014 | |
| 458 | Phosphorylation | ISTLVRAYLLTKDHI HHHHHHHHHHCCCHH | 7.53 | 18491316 | |
| 536 | Phosphorylation | KLGKEARSLYERGME HHHHHHHHHHHHHHH | 42.21 | 28796482 | |
| 538 | Phosphorylation | GKEARSLYERGMESL HHHHHHHHHHHHHHH | 12.58 | 28796482 | |
| 544 | Phosphorylation | LYERGMESLKAMLPL HHHHHHHHHHHHHCE | 26.69 | 28796482 | |
| 552 | Phosphorylation | LKAMLPLYDTGSGTI HHHHHCEEECCCCEE | 14.98 | 25072903 | |
| 554 | Phosphorylation | AMLPLYDTGSGTIYD HHHCEEECCCCEEEE | 21.49 | 25072903 | |
| 556 | Phosphorylation | LPLYDTGSGTIYDLR HCEEECCCCEEEEHH | 34.55 | 25072903 | |
| 558 | Phosphorylation | LYDTGSGTIYDLRHF EEECCCCEEEEHHHH | 20.33 | 25072903 | |
| 560 | Phosphorylation | DTGSGTIYDLRHFML ECCCCEEEEHHHHHH | 14.57 | 22817900 | |
| 612 | Phosphorylation | WKSYLKGSRAKHN-- HHHHHHCCCCCCC-- | 27.72 | 23186163 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GLCE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GLCE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GLCE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of GLCE_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-225, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-560, AND MASSSPECTROMETRY. | |